The constitutive activation of NF-κB is a hallmark of several types of cancers [115–117] and is heavily associated with cancer cell resistance to cytotoxic agents, due in part to its induced upregulation of anti-apoptotic proteins [118]. Here, NFKB1 is linked to cancer.